TDS Pharm Co. Ltd. engages in the development and manufacture of transdermal drug delivery systems. Its products include cataplasma, plasta, fucidin band, and prescription drugs. The company was founded on November 11, 2002 and is headquartered in Seongnam-si, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company